TCTAP 2024

PROTECT-HBR Trial: New GI Protection Drug for High-Bleeding Risk Patients Requiring Antithrombotic Agents - P-CAB vs. PPI

- Presenter : Jinho Lee

Leave a comment

Sign in to leave a comment.